Trials / Conditions / SARS-CoV-2 Virus Infection
SARS-CoV-2 Virus Infection
3 registered clinical trials studyying SARS-CoV-2 Virus Infection.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Safety and Immunogenicity of VLA2001 Adults Aged ≥56 Years NCT04956224 | Valneva Austria GmbH | Phase 3 |
| Completed | COV-COMPARE Immunogenicity of Vaccine VLA2001 Compared to AZD1222 NCT04864561 | Valneva Austria GmbH | Phase 3 |
| Completed | Dose Finding Study to Evaluate The Safety, Tolerability and Immunogenicity of an Inactiviated, Adjuvanted SARS NCT04671017 | Valneva Austria GmbH | Phase 1 / Phase 2 |